Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T19:26:08.885Z Has data issue: false hasContentIssue false

Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa

Published online by Cambridge University Press:  15 May 2009

A. Mates
Affiliation:
Department of Life Science, Bar-Ilan University, Ramat-Gan, Israel
P. Zand
Affiliation:
Department of Life Science, Bar-Ilan University, Ramat-Gan, Israel
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Active protection against Pseudomonas aeruginosa could be induced in mice by immunization with either the phenol killed cells or the alcohol precipitated fraction of the slime layer, or the ribosomal vaccine preparation. Passive protection could also be induced by injecting into mice antisera prepared in rabbits against these bacteria. This protection was due to the production of antibodies in reaction to the slime layer; the absorption of these antibodies by the slime caused the loss of protection. The fact that mice were also protected by vaccination with strains other than those used for challenging was attributed to the presence of an antigenically similar slime. Passive protection towards a heterologous strain, even one with an antigenically similar slime layer, was dependent on the dose of the challenging injection.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1974

References

REFERENCES

Alms, T. H. & Bass, J. A. (1965). Mouse protective antigen from Pseudomonas aeruginosa. Texas Reports on Biology and Medicine 23, 140.Google Scholar
Alms, T. H. & Bass, J. A. (1967 a). Immunization against Pseudomonas aeruginosa. I. Induction of protection by an alcohol precipitated fraction from the slime layer. Journal of Infectious Diseases 117, 249–56.CrossRefGoogle ScholarPubMed
Alms, T. H. & Bass, J. A. (1967 b). Immunization against Pseudomonas aeruginosa. II. Purification and characterization of the protective factor from the alcohol precipitated fraction. Journal of Infectious Diseases 117, 257–64.CrossRefGoogle ScholarPubMed
Avrameas, S., Taunou, B. & Chuilon, S. (1969). Glutaraldehyde, cyanuric chloride and tetraazotized o−dianisidine as coupling reagents in the passive hemagglutination test. Immunochemistry 6, 6776.CrossRefGoogle Scholar
Bass, J. A. & McCoy, J. (1971). Passive immunization against experimental Pseudomonas infection: Correlation of protection to Verder and Evans ‘O’ serotypes. Infection and Immunity 3, 51–8.CrossRefGoogle Scholar
Feingold, D. S. & Oski, F. (1965). Pseudomonas infection. Treatment with immune human plasma. Archives of Internal Medicine 116, 326–8.CrossRefGoogle Scholar
Feller, I. (1967). Control of Pseudomonas infections by the immune processes. Journal of Trauma 7, 93–5.Google ScholarPubMed
Feller, I. & Pearson, C. (1968). Pseudomonas vaccine and hyperimmune plasma for burned patients. Archives of Surgery 97, 225–9.CrossRefGoogle ScholarPubMed
Finland, M. (1970). Changing ecology of bacterial infection as related to antibacterial therapy. Journal of Infectious Diseases 122, 419–31.CrossRefGoogle ScholarPubMed
Fisher, M. W., Devlin, H. B. & Gnabasik, F. J. (1969). New immunotype scheme for Pseudomonas aeruginosa based on protective antigens. Journal of Bacteriology 98, 835–6.CrossRefGoogle Scholar
Gaines, S. & Landy, M. (1955). Prevalence of antibody to Pseudomonas in normal human serum. Journal of Bacteriology 69, 628–33.CrossRefGoogle Scholar
Johnston, L. J. & Syeklocha, D. (1972). Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa. Canadian Journal of Microbiology 18, 1607–11.CrossRefGoogle ScholarPubMed
Jones, R. J. (1968). Protection against Pseudomonas aeruginosa infection by immunization with fractions of culture filtrates of Pseudomonas aeruginosa. British Journal of Experimental Pathology 49, 411–20.Google ScholarPubMed
Jones, R. J. (1972). Specificity of early protective response induced by Pseudomonas vaccine. Journal of Hygiene 70, 343–51.CrossRefGoogle Scholar
Habs, I. (1957). Untersuchugen über die ‘O’ Antigene von Pseudomonas aeruginosa. Zeitschrift für Hygiene und Infektionskrankheiten 144, 218–20.CrossRefGoogle Scholar
Laborde, J. F. & de Fajarodo, C. L. (1965). Pseudomonas vaccine. I. Preparation and assay. Journal of Bacteriology 90, 290–1.CrossRefGoogle Scholar
Lindberg, R. B., Moncrief, J. A., Switzer, W. E., Order, S. E. & Mills, W. (1965). The successful control of burn wound sepsis. Journal of Trauma 5, 601–12.Google ScholarPubMed
Liu, P. V., Abe, Y. & Bates, J. L. (1961). The roles of various fractions of Pseudomonas aeruginosa in its pathogensis. Journal of Infectious Diseases 108, 218–28.CrossRefGoogle Scholar
Markley, K. (1967). Immunotherapy of Pseudomonas infection. Annals of Internal Medicine 66, 443–5.Google Scholar
Pierson, C. & Feller, I. (1970). A reduction of Pseudomonas aeruginosa septicemias in burned patients by the immune process. Surgical Clinics of North America 50, 1377–83.CrossRefGoogle Scholar
Schwartzmann, S. & Boring, J. R. (1971). Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infection and Immunity 3, 762–7.CrossRefGoogle Scholar
Stone, H. H., Graber, C. D., Martin, J. D. & Kolb, L. (1965). Evaluation of gamma globulin for prophylaxis against burn sepsis. Surgery 58, 810.Google ScholarPubMed
Youmans, A. S. & Youmans, G. P. (1966). Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate. Journal of Bacteriology 91, 2139–45.CrossRefGoogle ScholarPubMed
Verder, E. & Evans, J. (1961). A proposed antigenic schema for the identification of strains of Pseudomonas aeruginosa. Journal of Infectious Diseases 109, 183–93.CrossRefGoogle ScholarPubMed